Kura Oncology, Inc.
Status: Publicly traded
Direct answer
Kura Oncology, Inc. is publicly traded on NASDAQ under the ticker KURA.
Kura Oncology, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to discovering and advancing cancer treatments within the United States. Its therapeutic portfolio primarily features small-molecule compounds engineered to combat various cancers. Among its leading drug candidates is ziftomenib, a small-molecule agent designed to disrupt the interaction of menin-Lysine K-specific...
Can you invest in Kura Oncology, Inc.?
Yes. Kura Oncology, Inc. trades publicly on NASDAQ as KURA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kura Oncology, Inc.
Detailed equity research is provided by MarketSnap.